Your doctor may start you on a low dose of transdermal selegiline and gradually increase your dose, not more often than once every 2 weeks
(-)-selegiline is a selegiline and a terminal acetylenic compound
Selegiline transdermal side effects
The chemical name is: (R)-(-)-N,α-Dimethyl-N-2-propynylphenethylamine hydrochloride
- Antiparkinsonian Agents
In the randomized placebo-controlled double-blind trial, combination treatment was continued for 5 years followed by 1-month selegiline washout
This product is available in the following dosage forms: Selegiline skin patch may cause some people to be agitated, irritable, or display other abnormal behaviors
It is also sold under the name “deprenyl”
It is commonly referred to in the clinical and pharmacological literature as l-deprenyl
Selegiline was the first MAO-B inhibitor introduced onto the market, followed by rasagiline 15 years later [8, 13]
sinus pain or stuffy nose
14), is synthesized by the alkylation of (–)methyamphetamine (8